Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Jun 3, 2020
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-05-31$1.14/sh−301$343→ 169,046 total
4 · Nabriva Therapeutics plc · Filed Jun 3, 2020
Ordinary Shares